NCT06152289 2026-03-02
NOCE
Assistance Publique - Hôpitaux de Paris
Recruiting
Clinical Trials
55 trialsNCT07222800 2026-01-30
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Phase 3 Recruiting
NCT07253298 2025-11-28
BFT in LARS
National Taiwan University Hospital
Phase NA Not yet recruiting
NCT02246725 2025-09-12
ALLAN
Lund University Hospital
Completed
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT07086833 2025-07-25
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
Purdue University
Phase NA Recruiting
NCT03093116 2025-07-10
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT05551052 2025-05-29
CRC-DRAW
New Day Diagnostics
Active not recruiting
NCT01550510 2025-05-06
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Phase 1/2 Terminated
NCT04659590 2024-10-18
ORI-EGI-02
Origin Sciences
Completed
NCT06524362 2024-07-29
PERECARE
GEM Hospital & Research Center
Phase NA Not yet recruiting
NCT06435975 2024-05-30
Physical Activity in Rectal Cancer Survivors
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT02831556 2024-05-21
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
Completed
NCT00838578 2024-04-26
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
Phase 1/2 Terminated
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT03559543 2024-02-07
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT04134104 2023-11-13
Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy
National Academy of Medical Sciences, Nepal
Completed
NCT05605600 2023-04-05
Translation of the International Consensus Definition of LARS Into a Bowl Dysfunction Severity Scoring Tool (New LARS Score)
Cardiff and Vale University Health Board
Completed
NCT04970316 2023-02-28
LOSAPEX
University of Aarhus
Unknown
NCT04949282 2022-12-23
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Recruiting
NCT04893876 2022-08-18
The OPERa Study: Evaluating QoL After Rectal Cancer Surgery
Jewish General Hospital
Not yet recruiting
NCT05473325 2022-08-15
BRANCH-P
Willows Health
Unknown
NCT04080843 2022-07-13
ALTER-C-002
Zhejiang University
Phase 2 Completed
NCT05322486 2022-04-11
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
Unknown
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT02981524 2021-02-10
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04733794 2021-02-03
Feasibility Bowel Dysfunction Program After Low Anterior Resection
Fox Chase Cancer Center
Phase NA Completed
NCT04662853 2020-12-10
CCR-microbiota
Maimónides Biomedical Research Institute of Córdoba
Unknown
NCT04287335 2020-12-08
CLEAR-C
Zhejiang University
Completed
NCT01397305 2020-09-09
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT03920202 2019-04-18
LongLARS
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Completed
NCT02785783 2019-02-04
Erings™
Portsmouth Hospitals NHS Trust
Phase NA Completed
NCT02005965 2018-09-18
MERCURY II
Royal Marsden NHS Foundation Trust
Unknown
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT01995942 2018-09-14
MARVEL
Royal Marsden NHS Foundation Trust
Unknown
NCT03072472 2018-09-06
B-ADENOMA
South Tyneside and Sunderland NHS Foundation Trust
Phase NA Completed
NCT02503631 2018-04-06
Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Exact Sciences Corporation
Terminated
NCT00241722 2017-08-30
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT02141945 2017-03-28
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Corp
Completed
NCT01819766 2017-02-17
OCEANIA
Exact Sciences Corporation
Completed
NCT03009747 2017-01-04
PMCRBDSPS
Peking University People's Hospital
Unknown
NCT02503696 2016-08-10
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Exact Sciences Corporation
Completed
NCT01397747 2015-12-03
DeeP-C
Exact Sciences Corporation
Completed
NCT00135577 2015-09-02
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2 Completed
NCT00256932 2015-09-02
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed
NCT00259922 2015-09-02
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3 Completed